David Matthew Stark Teva Pharmaceutical Industries LTD (TEVA) insider trading activity

David Matthew Stark is Exec. VP Chief Legal Officer of TEVA PHARMACEUTICAL INDUSTRIES LTD. Currently has a direct ownership of 2,974 shares of TEVA, which is worth approximately $65,695. The most recent transaction as insider was on Mar 07, 2023, when has been sold 49,475 shares (Ordinary Shares) at a price of $9.43 per share, resulting in proceeds of $466,549. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.97K

0% 3M change

0% 12M change

Total Value Held $65,695

David Matthew Stark Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 07 2023	SELL Open market or private sale	$466,549 $9.43 p/Share	49,475 Reduced 94.33%	2,974 Ordinary Shares
Mar 06 2023	SELL Open market or private sale	$163,755 $9.93 p/Share	16,491 Reduced 23.92%	52,449 Ordinary Shares
Mar 05 2023	BUY Exercise of conversion of derivative security	-	20,199 Added 22.66%	68,940 Ordinary Shares
Mar 04 2023	BUY Exercise of conversion of derivative security	-	45,767 Added 48.43%	48,741 Ordinary Shares
Feb 28 2023	SELL Open market or private sale	$626,857 $9.89 p/Share	63,383 Reduced 95.52%	2,974 Ordinary Shares
Feb 28 2023	BUY Exercise of conversion of derivative security	-	63,383 Added 56.94%	47,927 Ordinary Shares
Jul 28 2022	SELL Open market or private sale	$525,794 $9.04 p/Share	58,163 Reduced 95.14%	2,974 Ordinary Shares
Mar 07 2022	SELL Open market or private sale	$66,750 $7.37 p/Share	9,057 Reduced 12.9%	61,137 Ordinary Shares
Mar 05 2022	BUY Exercise of conversion of derivative security	-	20,199 Added 22.35%	70,194 Ordinary Shares
Mar 04 2022	SELL Open market or private sale	$173,940 $7.48 p/Share	23,254 Reduced 31.75%	49,995 Ordinary Shares
Mar 04 2022	BUY Exercise of conversion of derivative security	-	51,869 Added 47.98%	56,241 Ordinary Shares
Feb 28 2022	SELL Open market or private sale	$52,519 $8.14 p/Share	6,452 Reduced 23.18%	21,380 Ordinary Shares
Feb 28 2022	BUY Exercise of conversion of derivative security	-	18,430 Added 39.84%	27,832 Ordinary Shares
Feb 09 2022	SELL Open market or private sale	$55,357 $9.06 p/Share	6,110 Reduced 39.39%	9,402 Ordinary Shares
Feb 09 2022	BUY Exercise of conversion of derivative security	-	12,538 Added 44.7%	15,512 Ordinary Shares
May 11 2021	SELL Open market or private sale	$387,174 $10.22 p/Share	37,884 Reduced 92.72%	2,974 Ordinary Shares
May 11 2021	BUY Exercise of conversion of derivative security	-	37,884 Added 48.11%	40,858 Ordinary Shares
Mar 04 2021	SELL Open market or private sale	$147,240 $10.57 p/Share	13,930 Reduced 82.41%	2,974 Ordinary Shares
Mar 04 2021	BUY Exercise of conversion of derivative security	-	13,930 Added 45.18%	16,904 Ordinary Shares
Mar 01 2021	SELL Open market or private sale	$199,597 $10.83 p/Share	18,430 Reduced 86.11%	2,974 Ordinary Shares
Feb 28 2021	BUY Exercise of conversion of derivative security	-	18,430 Added 46.27%	21,404 Ordinary Shares
Feb 16 2021	SELL Open market or private sale	$43,657 $11.12 p/Share	3,926 Reduced 56.9%	2,974 Ordinary Shares
Feb 14 2021	BUY Exercise of conversion of derivative security	-	3,926 Added 36.26%	6,900 Ordinary Shares
Feb 09 2021	SELL Open market or private sale	$828,809 $12.69 p/Share	65,312 Reduced 95.64%	2,974 Ordinary Shares
Feb 09 2021	BUY Grant, award, or other acquisition	-	52,774 Added 43.59%	68,286 Ordinary Shares

Also insider at

ASRT

Assertio Holdings, Inc. Healthcare

Director

DMS